Lakefront Biotherapeutics (LKFT) Non Operating Investment Income (2017 - 2018)

Lakefront Biotherapeutics (LKFT) reported Non Operating Investment Income of -$2.4 million for Q3 2018, down 130.03% year-over-year from $8.1 million in Q3 2017, and down 130.03% quarter-over-quarter from $8.1 million in Q3 2017.

Lakefront Biotherapeutics (LKFT) Non Operating Investment Income (2017 - 2018) Analysis & Trends

Lakefront Biotherapeutics (LKFT) has 2 years of Non Operating Investment Income data on file, last reported at -$2.4 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 235,807.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 230,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Lakefront Biotherapeutics 9.64 Bn 9.64 Bn 1.97 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 -2.43 Mn
Sep 30, 2018 -2.43 Mn
Sep 30, 2017 8.09 Mn
Sep 30, 2017 8.09 Mn